Tacrolimus for Kidney Failure (EVOKE-RT Trial)

"Affirmative, the latest information on clinicaltrials.gov reveals that this research is actively looking for participants to join in. The trial was initially made available on January 16th 2020 and has been recently updated November 7th 2022; 54 patients are being sought from a single location."

"At present, there are 18 Phase 3 trials and 150 active clinical studies researching Envarsus. Nashville, Tennessee is the hub for this research with 871 locations running related experiments."

"Aye, the latest update on clinicaltrials.gov affirms that this medical trial is still recruiting subjects. It was first opened to enrolment back in January 16th 2020 and has been recently refreshed November 7th 2022. Thus far, 54 participants have joined from a single location."

"Envarsus is a commonly-used treatment for atopic dermatitis, as well as rejection of liver and kidney transplants, and psoriasis."

"The security of Envarsus has been preliminarily established, thus it is given a rating of 3 on the scale. This reflects the fact that this drug has already received approval to enter Phase 4 trials."

"This clinical trial needs to recruit 54 volunteers, aged between 18 and 70 years old, who have been diagnosed with renal failure. For eligibility into this research study, participants must be able to attend Sentara Norfolk General Hospital for a kidney transplant."

"This clinical trial requires participants to be between 18 and 70 years old. There are separate trials for those younger than 18, with 52 studies accessible, as well as 277 other options available for patients over 65."